ICAGEN, INC.

Profile

Company Names

ICAGEN, INC.
XRPRO SCIENCES, INC.
CALDERA PHARMACEUTICALS INC

Addresses

4222 EMPEROR BLVD., SUITE 350, RESEARCH TRIANGLE PARK, DURHAM, NC 27703

4222 EMPEROR BLVD., SUITE 350, DURHAM, NC 27703

ONE KENDALL SQUARE, SUITE B2002, BOSTON, MA 02139

ONE KENDALL SQUARE, SUITE B2002, CAMBRIDGE, MA 02139

278 DP ROAD, SUITE D, LOS ALAMOS, NM 87544

278 DP ROAD SUITE D, LOS ALAMOS, NM 87544

Phone Numbers

919-941-5206
(919) 941-5206
(617) 631-8825
(505) 661-2420
505-601-2420

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$27,482,950.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2018-08-31 
$7,250,000.00 
$7,250,000.00 
$0.00 
Debt 
8
2018-08-13 
$500,000.00 
$1,500,000.00 
$1,000,000.00 
Debt 
7
2018-04-04 
$2,000,000.00 
$4,000,000.00 
$2,000,000.00 
Equity 
6
2017-05-15 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
5
2017-04-12 
$1,500,000.00 
$1,500,000.00 
$0.00 
Debt 
4
2016-06-27 
$1,145,000.00 
$1,145,000.00 
$0.00 
Debt 
3
2014-12-10 
$8,855,000.00 
$8,855,000.00 
$0.00 
Equity 
2
2013-04-17 
$3,135,000.00 
$5,000,000.00 
$1,865,000.00 
Equity 
1
2011-05-13 
$1,097,950.00 
$2,000,000.00 
$902,050.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
CUNNINGHAM 
EXECUTIVE OFFICER
MARK 
 
KORB 
EXECUTIVE OFFICER
DOUGLAS 
 
KRAFTE 
EXECUTIVE OFFICER, DIRECTOR
EDWARD 
 
ROFFMAN 
DIRECTOR
TIMOTHY 
 
TYSON 
DIRECTOR
BENJAMIN 
 
WARNER 
DIRECTOR, EXECUTIVE OFFICER
JEREMIEL 
 
ZIMMERMAN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2018-08-31 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2018-08-13 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2018-04-04 
D
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2017-05-15 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2017-04-12 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2016-06-27 
D/A
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2014-12-10 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2014-12-10 
D/A
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2013-04-17 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2013-04-17 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
TAGLICH BROTHERS, INC. ("TAGLICH")
NONE
NONE
TAGLICH BROTHERS, INC.
TAGLICH BROTHERS, INC.
VINCENT PALMIERI
NONE
TAGLICH BROTHERS, INC.
VINCENT MICHAEL PALMIERI
NONE
NONE
NONE
NONE